The application of the new recommendations, using the risk factor profile of the cohort of the NHANES-III National Health and Nutrition Examination Survey-III 2005-2010 3773 participants, extrapolated to the entire United States population aged from 40 years to 75 years 115.4 million people, would increase the number of people eligible for statin treatment from 43.2 million 37.5% to 56 million 48.6%, and most of this difference 10.4 million of 12.8 million people would be represented by people without CVD.
Aplicando la nueva guía, con el perfil de factores de riesgo de la cohorte del National Health and Nutrition Examination Survey-III NHANES-III, 2005-2010 3.773 participantes extrapolado a toda la población estadounidense 40-75 años 115,4 millones de personas, el número de sujetos susceptibles de tratamiento con estatinas aumentaría de 43,2 millones 37,5% a 56 millones 48,6% y la mayor parte de esta diferencia 10,4 de 12,8 millones serían personas sin ECV.